Category Archives: HIV/AIDS

Guide gives direction to the last 90

By on .

The following is a guest post By Sharon Weir, Ph.D. of MEASURE Evaluation For almost 35 years, HIV/AIDS has been a household word across the globe. At first a death sentence, HIV has infected 78 million people, killing almost half of them as the world battled it into submission as a treatable, chronic—but still dangerous—condition. […]

Dolutegravir results in low-resource setting highlight benefits

By on .

A standard of care treatment in high-income settings, the benefits of dolutegravir-based treatments for HIV have been clear, with a built-in barrier to the development of drug-resistance, and a less frequent or severe side effects that interfere with staying on a medicine. But the benefits in low-income countries have been harder to assess, with costs, […]

Can counseling, links to services cut death rates in half among people with HIV who inject drugs?

By on .

A study across three countries where HIV incidence is fueled by substance use found that a little support went a long way for people living with the virus and injecting drugs — helping them to stay on antiretroviral treatment and opioid substitution therapy, and keep their viral levels suppressed. The study, at health centers in […]

As deadline approaches for HIV control testing and treatment targets, sex workers still face “glaring gaps” between services and access

By on .

Authors of 2014 recommendations to tackle HIV among sex workers revisit literature and find impacts of pandemic, structural drivers continue to be “under addressed and under-resourced” When, in the months leading up to the 2014 International AIDS Conference in Melbourne, a team of researchers put together a series of articles examining the drivers and impacts  […]

Access to on-the-spot testing led to improved rates of treatment for infants with HIV

By on .

Tests to detect HIV in infants conducted at health facilities where they received care led to a significant increase in the percentage of infants with the virus given access to life-saving treatment, compared to tests analyzed in central laboratories, according to a report in Clinical Infectious Diseases. The report notes that the findings have critical […]

UNAIDS global HIV data shows “miles to go”

By on .

The tale of two global HIV responses continues to unfold this week, in data released by UNAIDS in the run-up to the 22nd International AIDS Conference in Amsterdam. One response, driven by antiretroviral treatment and pre-exposure prophylaxis, by unhindered access to health services and education, by the decriminalization of drug use and sex work, along […]

An affirmation on the way to AIDS 2018: Much has changed, not enough, and some for the worse

By on .

In calls for improved inclusiveness, evidence-based expenditures, and people-based policies, screeds released in advance of International AIDS Conferences tend to echo those of the year before, holding, if not advancing, established intentions. This year’s, an “affirmation,” rather than a “declaration” seems to acknowledge that in its title, but it also notes significant changes — in […]

What do you read, to track 25 years of HIV stigma and progress? Words, words, words . . .

By on .

From the first International AIDS Conference in Atlanta with about a thousand attendees in 1985, to the upcoming one in Amsterdam where about 18,000 are expected later this month, the annual, and then biennial meetings served as milestones in a slow climb of scientific, political and community progress against the pandemic. Memorable peaks include the […]

In Lesotho, where life expectancy is under 50, the last to test for HIV are the hardest to reach

By on .

Clinics for men, adolescent-dedicated sections in existing clinics, and increased support for community-based services are all needed to expand the reach of HIV testing in Lesotho, and offer hope of controlling the epidemic in a country where the virus is responsible for one of the shortest life expectancies in the world, according to a report […]

What we’re reading: Testing lag highlights role of healthcare access in HIV prevention and more about knowing the right thing to do, but . . .

By on .

Tests are lagging and the end of the epidemic is far away – How can it be that nearly four decades after what later became known as HIV was first recognized as a syndrome killing men who had sex with men, and more than a decade since U.S. public health officials recommended routine testing as […]